An abortion pill ruling has temporarily restored full nationwide access to mifepristone after the Supreme Court intervened in a legal dispute over restrictions imposed by a lower court.
The decision follows a ruling by the US Court of Appeals for the Fifth Circuit, which had required in-person dispensing of the drug, effectively limiting access through mail delivery.
In two brief orders, Justice Samuel Alito, a conservative member of the Supreme Court, said the Fifth Circuit ruling would remain on hold at least until 11 May 2026.
Alito issued the order in his capacity as the justice handling emergency applications from the appellate court, which covers Texas, Louisiana and Mississippi.
The move ensures that current access rules for mifepristone remain in place while the broader legal process continues.
Background to the legal dispute
The case centres on restrictions introduced by lower courts that would have required patients to obtain the abortion pill through in-person medical appointments.
Critics argued this would significantly reduce access to the medication, particularly for individuals relying on telemedicine and mail delivery services.
The Supreme Court’s temporary intervention maintains the status quo while the legal challenge continues through the federal court system.
The ruling comes amid ongoing legal and political disputes in the United States over reproductive healthcare and access to abortion medication.
Mifepristone has been widely used for medication abortions in the US for over two decades, and its regulation remains a central issue in national legal battles.
Further court proceedings are expected as the case continues to move through the federal judiciary.
Also read: Occupied Cyprus IVF clinics face claims of using wrong donors
For more videos and updates, check out our YouTube channel
